ITGAE and colitis: In addition to decreased α4ß7 integrin expression with WIN 18,446 treatment in Mdr1a−/− colitis, we observed increased percentages of cells expressing CD103 in all T cell subsets evaluated, with the magnitude of the change being highest in the Th17 cell subset.